150 related articles for article (PubMed ID: 33972990)
21. Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction.
Mariette C; Castel B; Balon JM; Van Seuningen I; Triboulet JP
Eur J Surg Oncol; 2003 Sep; 29(7):588-93. PubMed ID: 12943624
[TBL] [Abstract][Full Text] [Related]
22. Using textbook outcome as a measure of quality of care in oesophagogastric cancer surgery.
van der Kaaij RT; de Rooij MV; van Coevorden F; Voncken FEM; Snaebjornsson P; Boot H; van Sandick JW
Br J Surg; 2018 Apr; 105(5):561-569. PubMed ID: 29465746
[TBL] [Abstract][Full Text] [Related]
23. Minimally invasive oesophagectomy in Wales.
Chan DS; Baker AL
Surgeon; 2016 Aug; 14(4):196-201. PubMed ID: 25596667
[TBL] [Abstract][Full Text] [Related]
24. Anastomotic leakage after intrathoracic versus cervical oesophagogastric anastomosis for oesophageal carcinoma in Chinese population: a retrospective cohort study.
Liu YJ; Fan J; He HH; Zhu SS; Chen QL; Cao RH
BMJ Open; 2018 Sep; 8(9):e021025. PubMed ID: 30181184
[TBL] [Abstract][Full Text] [Related]
25. Impact of postoperative complications on disease recurrence and long-term survival following oesophagogastric cancer resection.
Saunders JH; Yanni F; Dorrington MS; Bowman CR; Vohra RS; Parsons SL;
Br J Surg; 2020 Jan; 107(1):103-112. PubMed ID: 31869460
[TBL] [Abstract][Full Text] [Related]
26. International benchmarking in oesophageal and gastric cancer surgery.
Busweiler LAD; Jeremiasen M; Wijnhoven BPL; Lindblad M; Lundell L; van de Velde CJH; Tollenaar RAEM; Wouters MWJM; van Sandick JW; Johansson J; Dikken JL
BJS Open; 2019 Feb; 3(1):62-73. PubMed ID: 30734017
[TBL] [Abstract][Full Text] [Related]
27. Value of individual surgeon performance metrics as quality assurance measures in oesophagogastric cancer surgery.
Powell AGMT; Wheat J; Patel N; Chan D; Foliaki A; Roberts SA; Lewis WG;
BJS Open; 2020 Feb; 4(1):91-100. PubMed ID: 32011808
[TBL] [Abstract][Full Text] [Related]
28. Oesophagectomy for carcinoma of the oesophagus and oesophagogastric junction.
Dalrymple-Hay MJ; Evans KB; Lea RE
Eur J Cardiothorac Surg; 1999 May; 15(5):626-30. PubMed ID: 10386408
[TBL] [Abstract][Full Text] [Related]
29. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection.
Cense HA; van Eijck CH; Tilanus HW
Best Pract Res Clin Gastroenterol; 2006; 20(5):893-906. PubMed ID: 16997168
[TBL] [Abstract][Full Text] [Related]
30. Defining a positive circumferential resection margin in oesophageal cancer and its implications for adjuvant treatment.
O'Neill JR; Stephens NA; Save V; Kamel HM; Phillips HA; Driscoll PJ; Paterson-Brown S
Br J Surg; 2013 Jul; 100(8):1055-63. PubMed ID: 23616367
[TBL] [Abstract][Full Text] [Related]
31. Individualised surgical treatment of patients with an adenocarcinoma of the distal oesophagus or gastro-oesophageal junction.
Hulscher JB; van Lanschot JJ
Dig Surg; 2005; 22(3):130-4. PubMed ID: 15942237
[TBL] [Abstract][Full Text] [Related]
32. Multimodality treatment for esophageal cancer: the role of surgery and neoadjuvant therapy.
Makary MA; Kiernan PD; Sheridan MJ; Tonnesen G; Hetrick V; Vaughan B; Graling P; Elster E
Am Surg; 2003 Aug; 69(8):693-700; discussion 700-2. PubMed ID: 12953828
[TBL] [Abstract][Full Text] [Related]
33. Systemic inflammatory markers and outcome in patients with locally advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction.
Jagadesham VP; Lagarde SM; Immanuel A; Griffin SM
Br J Surg; 2017 Mar; 104(4):401-407. PubMed ID: 28072456
[TBL] [Abstract][Full Text] [Related]
34. Total thoracic oesophagectomy for oesophageal carcinoma: has it been worth it?
McManus K; Anikin V; McGuigan J
Eur J Cardiothorac Surg; 1999 Sep; 16(3):261-5. PubMed ID: 10554840
[TBL] [Abstract][Full Text] [Related]
35. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer.
Tamandl D; Paireder M; Asari R; Baltzer PA; Schoppmann SF; Ba-Ssalamah A
Eur Radiol; 2016 May; 26(5):1359-67. PubMed ID: 26334504
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.
Shapiro J; van Lanschot JJB; Hulshof MCCM; van Hagen P; van Berge Henegouwen MI; Wijnhoven BPL; van Laarhoven HWM; Nieuwenhuijzen GAP; Hospers GAP; Bonenkamp JJ; Cuesta MA; Blaisse RJB; Busch ORC; Ten Kate FJW; Creemers GM; Punt CJA; Plukker JTM; Verheul HMW; Bilgen EJS; van Dekken H; van der Sangen MJC; Rozema T; Biermann K; Beukema JC; Piet AHM; van Rij CM; Reinders JG; Tilanus HW; Steyerberg EW; van der Gaast A;
Lancet Oncol; 2015 Sep; 16(9):1090-1098. PubMed ID: 26254683
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant chemoradiotherapy or chemotherapy alone for oesophageal cancer: population-based cohort study.
Kamarajah SK; Phillips AW; Ferri L; Hofstetter WL; Markar SR
Br J Surg; 2021 Apr; 108(4):403-411. PubMed ID: 33755097
[TBL] [Abstract][Full Text] [Related]
38. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer.
Dexter SP; Sue-Ling H; McMahon MJ; Quirke P; Mapstone N; Martin IG
Gut; 2001 May; 48(5):667-70. PubMed ID: 11302966
[TBL] [Abstract][Full Text] [Related]
39. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
[TBL] [Abstract][Full Text] [Related]
40. Improved survival in resected oesophageal and gastric adenocarcinomas over a decade: the Royal Marsden experience 2001-2010.
Fontana E; Smyth EC; Cunningham D; Rao S; Watkins D; Allum WH; Thompson J; Waddell T; Peckitt C; Chau I; Starling N
Gastric Cancer; 2016 Oct; 19(4):1114-1124. PubMed ID: 26541768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
